Combining immunotherapy and epidermal growth factor receptor kinase inhibitors: worth the risk?.

MedStar author(s):
Citation: Annals of Translational Medicine. 7(Suppl 3):S76, 2019 Jul.PMID: 31576285Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2019ISSN:
  • 2305-5839
Name of journal: Annals of translational medicineAll authors: Latif H, Liu SVFiscal year: FY2020Digital Object Identifier: Date added to catalog: 2019-10-14
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 31576285 Available 31576285

English

Powered by Koha